May 31, 2017   SOURCE: PR NewsWire

BioMarin to Attend Upcoming Investor Conference

SAN RAFAEL, Calif., May 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Dan Spiegelman, Executive Vice President and Chief Financial Officer, will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on June 13, 2017 at 1:20pm PT/4:20pm ET, in Rancho Palos Verdes, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

    Contacts:

    Investors                                   Media

    Traci McCarty                               Debra Charlesworth

    BioMarin Pharmaceutical Inc.                BioMarin Pharmaceutical Inc.

    (415) 455-7558                              (415) 455-7451

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conference-300465840.html

SOURCE BioMarin Pharmaceutical Inc.